Uniphar (LON:UPR) Sets New 1-Year High – Still a Buy?

Uniphar plc (LON:UPR)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 314 ($4.26) and last traded at GBX 310 ($4.20), with a volume of 11207 shares. The stock had previously closed at GBX 307 ($4.16).

Analyst Ratings Changes

Separately, Shore Capital reiterated a “buy” rating on shares of Uniphar in a research note on Thursday, May 29th.

Uniphar Stock Up 2.3%

The firm has a market cap of £1.02 billion, a PE ratio of 22.76 and a beta of 0.75. The company has a debt-to-equity ratio of 119.48, a quick ratio of 0.60 and a current ratio of 0.90. The firm’s 50-day moving average price is GBX 264.76 and its two-hundred day moving average price is GBX 219.25.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.